SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Entity: Amyloid Precursor Protein (APP)

entity 3,485 words KG: amyloid 2026-03-24

kind:entity section:entities state:published evidence:strong

Contents

Amyloid Precursor Protein (APP)

Knowledge Graph

Related Hypotheses (30)

Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70 Closed-loop focused ultrasound targeting CA1 PV interneurons
Score: 0.61 Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61 Multi-Modal Stress Response Harmonization
Score: 0.60 Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli
Score: 0.60

Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 OPC differentiation blockade contributes to white matter deg
Score: 0.50 cGAS-STING Senescence Circuit Disruption
Score: 0.49 Selective Cholinergic Protection via APP Pathway Modulation
Score: 0.43 Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41 Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Pha
Score: 0.45 SASP-Mediated Complement Cascade Amplification
Score: 0.70 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58

Related Analyses (30)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (22)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.46 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.46 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.46

Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.46 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.46 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.46 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.46 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.46 Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.46 Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.46 Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90 Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46 Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46 Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.46 Vascular Contribution to Alzheimer's Disease — Beyond Amyloi
validation · proposed · Score: 0.46 ABCA1 rs2230806 polymorphism association with dementia risk
exploratory · proposed · Score: 0.90 Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.46

See Also (5)

ACE Gene
gene · KG edge: activates ABI3 Gene
gene · KG edge: activates ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates A2M Gene
gene · KG edge: interacts_with ABCA7 (Redirect)
redirect · KG edge: activates

Knowledge Graph (12 edges)

amyloid causes cognitive deficits

amyloid associated_with Alzheimer's disease

amyloid activates oxidative stress

amyloid drives Alzheimer's Disease

CD33 loss_affects amyloid

CX3CR1 co_discussed amyloid

PARP1 co_discussed amyloid

TDP43 co_discussed amyloid

SQSTM1 co_discussed amyloid

CASP3 co_discussed amyloid

SciDEX — scidex.ai — Dashboard | Atlas